These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34454584)

  • 21. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
    Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
    Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment.
    Peter MR; Bilenky M; Isserlin R; Bader GD; Shen SY; De Carvalho DD; Hansen AR; Hu P; Fleshner NE; Joshua AM; Hirst M; Bapat B
    Epigenomics; 2020 Aug; 12(15):1317-1332. PubMed ID: 32867540
    [No Abstract]   [Full Text] [Related]  

  • 23. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.
    Kim YJ; Jeon H; Jeon S; Lee SH; Kim C; Ahn JH; Um H; Woo YJ; Jeong SH; Kim Y; Park HY; Oh HJ; Cho HJ; Bae JH; Kim JH; An S; Kang SB; Jho S; Biro O; Kis D; Kim BC; Kim Y; Kim JH; Kim BC; Bhak J; Oh IJ
    Mol Cell Probes; 2022 Dec; 66():101873. PubMed ID: 36379302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
    Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
    FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
    Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation of the ITGB4 gene in prostate cancer.
    Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
    Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
    Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
    J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
    Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
    Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.
    Qi J; Hong B; Wang S; Wang J; Fang J; Sun R; Nie J; Wang H
    Cancer Sci; 2024 Oct; 115(10):3426-3438. PubMed ID: 39038922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-free DNA methylation patterns in aging and their association with inflamm-aging.
    Li SJ; Gao X; Wang ZH; Li J; Zeng LT; Dang YM; Ma YQ; Zhang LQ; Wang QY; Zhang YM; Liu HL; Qi RM; Cai JP
    Epigenomics; 2024; 16(10):715-731. PubMed ID: 38869474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methylome and cell-free DNA: current applications in medicine and pediatric disease.
    Spector BL; Harrell L; Sante D; Wyckoff GJ; Willig L
    Pediatr Res; 2023 Jul; 94(1):89-95. PubMed ID: 36646885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.
    Kwee S; Song MA; Cheng I; Loo L; Tiirikainen M
    Clin Transl Sci; 2012 Feb; 5(1):65-70. PubMed ID: 22376260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer.
    Peter MR; Bilenky M; Shi Y; Pu J; Kamdar S; Hansen AR; Fleshner NE; Sridhar SS; Joshua AM; Hirst M; Xu W; Bapat B
    Epigenomics; 2022 Jul; 14(13):811-822. PubMed ID: 35818933
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
    Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
    Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential DNA Methylation in Prostate Tumors from Puerto Rican Men.
    Ruiz-Deya G; Matta J; Encarnación-Medina J; Ortiz-Sanchéz C; Dutil J; Putney R; Berglund A; Dhillon J; Kim Y; Park JY
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
    Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
    Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenomic alterations in localized and advanced prostate cancer.
    Lin PC; Giannopoulou EG; Park K; Mosquera JM; Sboner A; Tewari AK; Garraway LA; Beltran H; Rubin MA; Elemento O
    Neoplasia; 2013 Apr; 15(4):373-83. PubMed ID: 23555183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.